CLAIMBOUND / SOURCE-PUBLICATION EVIDENCE

Clinical trials

70 distinct source statements, not 70 independently proven facts. 70 results use an official primary source; 0 retain their explicitly limited Wikidata publication boundary.

Every card identifies what it proves, what it does not prove, its exact quote, locator, source hash, and local rerun command.

70 / 70primary-source statements
0 / 70independent ClaimBound reruns
CB7K-DOM019-C01registry slot CB7K-DOM019-T01-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

1. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 8

Narrow public claim

Clinical trials conducted in accordance with this standard will help to assure that the rights, safety and well-being of trial participants are protected; that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki; and that the clinical trial results are reliable.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Clinical trials conducted in accordance with this standard will help to assure that the rights, safety and well-being of trial participants are protected; that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki; and that the clinical trial results are reliable.
CB7K-DOM019-C02registry slot CB7K-DOM019-T01-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

2. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 8

Narrow public claim

Guideline Scope This guideline applies to interventional clinical trials of investigational products1 that are intended to be submitted to regulatory authorities.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Guideline Scope This guideline applies to interventional clinical trials of investigational products1 that are intended to be submitted to regulatory authorities.
CB7K-DOM019-C03registry slot CB7K-DOM019-T01-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

3. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 9

Narrow public claim

The principles outlined in this guideline may be satisfied using differing approaches and should be applied to fit the intended purpose of the clinical trial.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 9
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The principles outlined in this guideline may be satisfied using differing approaches and should be applied to fit the intended purpose of the clinical trial.
CB7K-DOM019-C04registry slot CB7K-DOM019-T01-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

4. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 9

Narrow public claim

Annex 1, including its Appendices, is intended to provide information on how the Principles can be appropriately applied to clinical trials.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 9
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Annex 1, including its Appendices, is intended to provide information on how the Principles can be appropriately applied to clinical trials.
CB7K-DOM019-C05registry slot CB7K-DOM019-T01-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

5. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 10

Narrow public claim

The principles are interdependent and should be considered in their totality to assure ethical trial conduct and reliable results.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 10
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The principles are interdependent and should be considered in their totality to assure ethical trial conduct and reliable results.
CB7K-DOM019-C06registry slot CB7K-DOM019-T01-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

6. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 10

Narrow public claim

The participant selection process should be representative of the population groups that the investigational product is intended to benefit, once authorised, to allow for generalising the results across the broader population.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 10
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The participant selection process should be representative of the population groups that the investigational product is intended to benefit, once authorised, to allow for generalising the results across the broader population.
CB7K-DOM019-C07registry slot CB7K-DOM019-T01-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

7. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 11

Narrow public claim

For potential participants unable to provide informed consent, their legally acceptable representatives, acting in the participants’ best interest, should provide consent prior to clinical trial participation.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
For potential participants unable to provide informed consent, their legally acceptable representatives, acting in the participants’ best interest, should provide consent prior to clinical trial participation.
CB7K-DOM019-C08registry slot CB7K-DOM019-T01-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

8. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 11

Narrow public claim

In the event that a minor is a participant, assent should be collected from that minor, as appropriate, and in accordance with local regulatory requirements (see ICH E11(R1) Clinical Investigation of Medicinal Products in the Pediatric Population).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In the event that a minor is a participant, assent should be collected from that minor, as appropriate, and in accordance with local regulatory requirements (see ICH E11(R1) Clinical Investigation of Medicinal Products in the Pediatric Population).
CB7K-DOM019-C09registry slot CB7K-DOM019-T01-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

9. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 12

Narrow public claim

Individuals involved in a trial should be qualified by education, training and experience to perform their respective task(s).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Individuals involved in a trial should be qualified by education, training and experience to perform their respective task(s).
CB7K-DOM019-C10registry slot CB7K-DOM019-T01-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

10. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 12

Narrow public claim

These factors are attributes of a trial that are fundamental to the protection of participants, the reliability and interpretability of the trial results and the decisions made based on those trial results.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
These factors are attributes of a trial that are fundamental to the protection of participants, the reliability and interpretability of the trial results and the decisions made based on those trial results.
CB7K-DOM019-C11registry slot CB7K-DOM019-T02-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

11. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 13

Narrow public claim

9.3 Computerised systems used in clinical trials should be fit for purpose (e.g., through risk-based validation, if appropriate), and factors critical to their quality should be addressed in their design or adaptation for clinical trial purposes to ensure the integrity of relevant trial data.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
9.3 Computerised systems used in clinical trials should be fit for purpose (e.g., through risk-based validation, if appropriate), and factors critical to their quality should be addressed in their design or adaptation for clinical trial purposes to ensure the integrity of relevant trial data.
CB7K-DOM019-C12registry slot CB7K-DOM019-T02-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

12. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 13

Narrow public claim

These essential records should be available to regulatory authorities, monitors, auditors and IRBs/IECs (as appropriate) upon request to enable appropriate evaluation of the trial conduct in order to ensure the reliability of trial results.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
These essential records should be available to regulatory authorities, monitors, auditors and IRBs/IECs (as appropriate) upon request to enable appropriate evaluation of the trial conduct in order to ensure the reliability of trial results.
CB7K-DOM019-C13registry slot CB7K-DOM019-T02-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

13. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 14

Narrow public claim

Where activities have been transferred or delegated to service providers, the responsibility for the conduct of the trial, including quality and integrity of the trial data, resides with the sponsor or investigator, respectively.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 14
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Where activities have been transferred or delegated to service providers, the responsibility for the conduct of the trial, including quality and integrity of the trial data, resides with the sponsor or investigator, respectively.
CB7K-DOM019-C14registry slot CB7K-DOM019-T02-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

14. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 15

Narrow public claim

For the submission to or communication with the IRB/IEC, in most regions where there is also a requirement to make a submission to the relevant regulatory authority, these may be combined in a single submission in accordance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
For the submission to or communication with the IRB/IEC, in most regions where there is also a requirement to make a submission to the relevant regulatory authority, these may be combined in a single submission in accordance with applicable regulatory requirements.
CB7K-DOM019-C15registry slot CB7K-DOM019-T02-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

15. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 15

Narrow public claim

Submissions and communications with the IRB/IEC and regulatory authorities are made in some regions by the investigator/institution and by the sponsor in other regions in accordance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Submissions and communications with the IRB/IEC and regulatory authorities are made in some regions by the investigator/institution and by the sponsor in other regions in accordance with applicable regulatory requirements.
CB7K-DOM019-C16registry slot CB7K-DOM019-T02-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

16. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 16

Narrow public claim

Payments to a participant should be timely, prorated and not wholly contingent on completion of the trial by the participant.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 16
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Payments to a participant should be timely, prorated and not wholly contingent on completion of the trial by the participant.
CB7K-DOM019-C17registry slot CB7K-DOM019-T02-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

17. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 16

Narrow public claim

It is recommended that the IRB/IEC should include: (a) At least five members; (b) At least one member whose primary area of interest is not in medical sciences; (c) At least one member who is independent of the institution/investigator site.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 16
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
It is recommended that the IRB/IEC should include: (a) At least five members; (b) At least one member whose primary area of interest is not in medical sciences; (c) At least one member who is independent of the institution/investigator site.
CB7K-DOM019-C18registry slot CB7K-DOM019-T02-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

18. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 19

Narrow public claim

The investigator may be supported by the sponsor in the identification of a suitable service provider(s); however, the investigator retains the final decision on whether the service provider intended to support the investigator is appropriate based on information provided by the sponsor (see section 3.6.5).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 19
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The investigator may be supported by the sponsor in the identification of a suitable service provider(s); however, the investigator retains the final decision on whether the service provider intended to support the investigator is appropriate based on information provided by the sponsor (see section 3.6.5).
CB7K-DOM019-C19registry slot CB7K-DOM019-T02-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

19. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 19

Narrow public claim

The investigator retains the ultimate responsibility and should maintain appropriate oversight of the persons or parties undertaking the activities delegated to ensure the rights, safety and well-being of the trial participants and the reliability of data.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 19
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The investigator retains the ultimate responsibility and should maintain appropriate oversight of the persons or parties undertaking the activities delegated to ensure the rights, safety and well-being of the trial participants and the reliability of data.
CB7K-DOM019-C20registry slot CB7K-DOM019-T02-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

20. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 20

Narrow public claim

In addition to those identified by the investigator themselves, protocol deviations relevant to their trial participants and their conduct of the trial may be communicated to them by the sponsor (see section 3.11.4.5.1(b)).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 20
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In addition to those identified by the investigator themselves, protocol deviations relevant to their trial participants and their conduct of the trial may be communicated to them by the sponsor (see section 3.11.4.5.1(b)).
CB7K-DOM019-C21registry slot CB7K-DOM019-T03-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

21. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 20

Narrow public claim

In either case, the investigator should review the deviations, and for those deviations deemed important, the investigator should explain the deviation and implement appropriate measures to prevent a recurrence, where applicable (see section 3.9.3).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 20
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In either case, the investigator should review the deviations, and for those deviations deemed important, the investigator should explain the deviation and implement appropriate measures to prevent a recurrence, where applicable (see section 3.9.3).
CB7K-DOM019-C22registry slot CB7K-DOM019-T03-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

22. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 21

Narrow public claim

(a) A qualified physician or, where appropriate, a qualified dentist (or other qualified healthcare professionals in accordance with local regulatory requirements) who is an investigator or a sub-investigator for the trial should have the responsibility for trial-related medical care and decisions.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 21
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(a) A qualified physician or, where appropriate, a qualified dentist (or other qualified healthcare professionals in accordance with local regulatory requirements) who is an investigator or a sub-investigator for the trial should have the responsibility for trial-related medical care and decisions.
CB7K-DOM019-C23registry slot CB7K-DOM019-T03-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

23. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 21

Narrow public claim

(b) Other appropriately qualified healthcare professionals may be involved in the medical care of trial participants, in line with their normal activities and in accordance with local regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 21
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(b) Other appropriately qualified healthcare professionals may be involved in the medical care of trial participants, in line with their normal activities and in accordance with local regulatory requirements.
CB7K-DOM019-C24registry slot CB7K-DOM019-T03-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

24. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 22

Narrow public claim

(b) All serious adverse events (SAEs) should be reported immediately (after the investigator reasonably becomes aware of the event) to the sponsor.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 22
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(b) All serious adverse events (SAEs) should be reported immediately (after the investigator reasonably becomes aware of the event) to the sponsor.
CB7K-DOM019-C25registry slot CB7K-DOM019-T03-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

25. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 22

Narrow public claim

In accordance with applicable regulatory requirements, the protocol may identify SAEs not requiring immediate reporting; for example, deaths or other events that are endpoints.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 22
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In accordance with applicable regulatory requirements, the protocol may identify SAEs not requiring immediate reporting; for example, deaths or other events that are endpoints.
CB7K-DOM019-C26registry slot CB7K-DOM019-T03-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

26. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 23

Narrow public claim

(e) Whether the informed consent process takes place in person or remotely, the investigator should assure themselves of the identity of the participant (or legally acceptable representative) in accordance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 23
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(e) Whether the informed consent process takes place in person or remotely, the investigator should assure themselves of the identity of the participant (or legally acceptable representative) in accordance with applicable regulatory requirements.
CB7K-DOM019-C27registry slot CB7K-DOM019-T03-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

27. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 23

Narrow public claim

The communication of this information and confirmation of the willingness to continue trial participation should be documented.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 23
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The communication of this information and confirmation of the willingness to continue trial participation should be documented.
CB7K-DOM019-C28registry slot CB7K-DOM019-T03-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

28. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 24

Narrow public claim

The informed consent process may involve a physical or an electronic signature and date (see the glossary term “signature”).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 24
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The informed consent process may involve a physical or an electronic signature and date (see the glossary term “signature”).
CB7K-DOM019-C29registry slot CB7K-DOM019-T03-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

29. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 24

Narrow public claim

When prior consent of the participant is not possible and the participant’s legally acceptable representative is not available, enrolment of the participant should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC, to protect the participant’s rights, safety and well-being and to ensure compliance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 24
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
When prior consent of the participant is not possible and the participant’s legally acceptable representative is not available, enrolment of the participant should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC, to protect the participant’s rights, safety and well-being and to ensure compliance with applicable regulatory requirements.
CB7K-DOM019-C30registry slot CB7K-DOM019-T03-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

30. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 26

Narrow public claim

During trial participation, the participant or the participant’s legally acceptable representative should receive a copy of the consent form updates and any other updated informed consent materials provided.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 26
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
During trial participation, the participant or the participant’s legally acceptable representative should receive a copy of the consent form updates and any other updated informed consent materials provided.
CB7K-DOM019-C31registry slot CB7K-DOM019-T04-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

31. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 26

Narrow public claim

A process for consent should be considered if, during the course of the trial, the minor reaches the age of legal consent, in accordance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 26
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A process for consent should be considered if, during the course of the trial, the minor reaches the age of legal consent, in accordance with applicable regulatory requirements.
CB7K-DOM019-C32registry slot CB7K-DOM019-T04-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

32. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 27

Narrow public claim

The investigator or delegated investigator site staff should consider explaining to the participant the value of continuing their participation to minimise trial participants withdrawal.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 27
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The investigator or delegated investigator site staff should consider explaining to the participant the value of continuing their participation to minimise trial participants withdrawal.
CB7K-DOM019-C33registry slot CB7K-DOM019-T04-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

33. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 27

Narrow public claim

In this process, the investigator should ensure that it does not interfere with the participant’s decision to refuse or withdraw participation at any time.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 27
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In this process, the investigator should ensure that it does not interfere with the participant’s decision to refuse or withdraw participation at any time.
CB7K-DOM019-C34registry slot CB7K-DOM019-T04-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

34. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 29

Narrow public claim

The investigator should review and endorse the reported data at important milestones agreed upon with the sponsor (e.g., interim analysis) (see section 3.16.1(o)).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 29
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The investigator should review and endorse the reported data at important milestones agreed upon with the sponsor (e.g., interim analysis) (see section 3.16.1(o)).
CB7K-DOM019-C35registry slot CB7K-DOM019-T04-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

35. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 33

Narrow public claim

(a) Where reference is made to a submission to the IRB/IEC, this can be made by the investigator/institution or sponsor in accordance with applicable regulatory requirements (see section 1.1).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 33
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(a) Where reference is made to a submission to the IRB/IEC, this can be made by the investigator/institution or sponsor in accordance with applicable regulatory requirements (see section 1.1).
CB7K-DOM019-C36registry slot CB7K-DOM019-T04-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

36. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 34

Narrow public claim

The sponsor should adopt a proportionate and riskbased approach to quality management, which involves incorporating quality into the design of the clinical trial (i.e., quality by design) and identifying those factors that are likely to have a meaningful impact on participants’ rights, safety and well-being and the reliability of the results (i.e., critical to quality factors as described in ICH E8(R1)).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 34
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The sponsor should adopt a proportionate and riskbased approach to quality management, which involves incorporating quality into the design of the clinical trial (i.e., quality by design) and identifying those factors that are likely to have a meaningful impact on participants’ rights, safety and well-being and the reliability of the results (i.e., critical to quality factors as described in ICH E8(R1)).
CB7K-DOM019-C37registry slot CB7K-DOM019-T04-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

37. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 34

Narrow public claim

The sponsor should describe the quality management approach implemented in the trial in the clinical trial report (see ICH E3 Structure and Content of Clinical Study Reports).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 34
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The sponsor should describe the quality management approach implemented in the trial in the clinical trial report (see ICH E3 Structure and Content of Clinical Study Reports).
CB7K-DOM019-C38registry slot CB7K-DOM019-T04-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

38. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 36

Narrow public claim

The sponsor should summarise and report important quality issues (including instances in which acceptable ranges are exceeded, as detailed in section 3.10.1.3) and the remedial actions taken and document them in the clinical trial report (see ICH E3).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 36
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The sponsor should summarise and report important quality issues (including instances in which acceptable ranges are exceeded, as detailed in section 3.10.1.3) and the remedial actions taken and document them in the clinical trial report (see ICH E3).
CB7K-DOM019-C39registry slot CB7K-DOM019-T04-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

39. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 36

Narrow public claim

When performed, audits should be conducted in a manner that is proportionate to the risks associated with the conduct of the trial (see section 3.10.1.1).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 36
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
When performed, audits should be conducted in a manner that is proportionate to the risks associated with the conduct of the trial (see section 3.10.1.1).
CB7K-DOM019-C40registry slot CB7K-DOM019-T04-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

40. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 39

Narrow public claim

(a) Selecting the site and confirming that the investigator and individuals or parties involved in the trial conduct have adequate qualifications, resources (see sections 2.1, 2.2 and 3.7) and facilities, including laboratories, equipment and investigator site staff, to conduct the trial safely and properly.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 39
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(a) Selecting the site and confirming that the investigator and individuals or parties involved in the trial conduct have adequate qualifications, resources (see sections 2.1, 2.2 and 3.7) and facilities, including laboratories, equipment and investigator site staff, to conduct the trial safely and properly.
CB7K-DOM019-C41registry slot CB7K-DOM019-T05-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

41. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 40

Narrow public claim

(d) Confirming that informed consent was obtained before participation in the trial (see section 2.8) for trial participants at the site.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 40
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(d) Confirming that informed consent was obtained before participation in the trial (see section 2.8) for trial participants at the site.
CB7K-DOM019-C42registry slot CB7K-DOM019-T05-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

42. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 43

Narrow public claim

(b) The sponsor should, in accordance with the applicable regulatory requirement(s) and with ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, expedite the reporting to the regulatory authority(ies) of all suspected, unexpected and serious adverse reactions (i.e., SUSARs).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 43
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(b) The sponsor should, in accordance with the applicable regulatory requirement(s) and with ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, expedite the reporting to the regulatory authority(ies) of all suspected, unexpected and serious adverse reactions (i.e., SUSARs).
CB7K-DOM019-C43registry slot CB7K-DOM019-T05-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

43. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 44

Narrow public claim

Alternatively, for authorised medicinal products, the sponsor should identify the basic product information to be used in the trial (see Appendix A, section A.1.1).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 44
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Alternatively, for authorised medicinal products, the sponsor should identify the basic product information to be used in the trial (see Appendix A, section A.1.1).
CB7K-DOM019-C44registry slot CB7K-DOM019-T05-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

44. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 47

Narrow public claim

(e) The sponsor should ensure that documented processes are implemented to ensure the data integrity for the full data life cycle (see section 4.2).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 47
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(e) The sponsor should ensure that documented processes are implemented to ensure the data integrity for the full data life cycle (see section 4.2).
CB7K-DOM019-C45registry slot CB7K-DOM019-T05-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

45. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 47

Narrow public claim

This enables the investigators to make decisions (e.g., on eligibility, treatment, continuing participation in the trial and care for the safety of the individual trial participants) (see section 2.12.3).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 47
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
This enables the investigators to make decisions (e.g., on eligibility, treatment, continuing participation in the trial and care for the safety of the individual trial participants) (see section 2.12.3).
CB7K-DOM019-C46registry slot CB7K-DOM019-T05-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

46. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 48

Narrow public claim

These steps may vary depending on the purpose of the analysis to be conducted (e.g., data for IDMC, for interim analysis or the final analysis) (see section 4.2.6).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 48
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
These steps may vary depending on the purpose of the analysis to be conducted (e.g., data for IDMC, for interim analysis or the final analysis) (see section 4.2.6).
CB7K-DOM019-C47registry slot CB7K-DOM019-T05-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

47. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 51

Narrow public claim

(b) The sponsor should ensure that trial participants have consented to direct access to source records for the purposes outlined in 3.16.4(a) (see section 2.8.10(n)).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 51
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(b) The sponsor should ensure that trial participants have consented to direct access to source records for the purposes outlined in 3.16.4(a) (see section 2.8.10(n)).
CB7K-DOM019-C48registry slot CB7K-DOM019-T05-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

48. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 51

Narrow public claim

The sponsor should also ensure that the clinical trial reports in marketing applications meet the standards of ICH E3 or are otherwise in accordance with applicable regulatory requirements.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 51
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The sponsor should also ensure that the clinical trial reports in marketing applications meet the standards of ICH E3 or are otherwise in accordance with applicable regulatory requirements.
CB7K-DOM019-C49registry slot CB7K-DOM019-T05-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

49. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 55

Narrow public claim

As described in sections 2 and 3, the responsibilities of the sponsor, investigator and the activities of other parties with respect to a computerised system used in clinical trials should be clear and documented.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 55
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
As described in sections 2 and 3, the responsibilities of the sponsor, investigator and the activities of other parties with respect to a computerised system used in clinical trials should be clear and documented.
CB7K-DOM019-C50registry slot CB7K-DOM019-T05-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

50. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 59

Narrow public claim

INVESTIGATOR’S BROCHURE A.1 Introduction The Investigator’s Brochure (IB) is a compilation of the clinical and nonclinical data on the investigational product(s)1 that are relevant to the study of the product(s) in human participants.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 59
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
INVESTIGATOR’S BROCHURE A.1 Introduction The Investigator’s Brochure (IB) is a compilation of the clinical and nonclinical data on the investigational product(s)1 that are relevant to the study of the product(s) in human participants.
CB7K-DOM019-C51registry slot CB7K-DOM019-T06-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

51. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 59

Narrow public claim

A.1.1 Development of the Investigator’s Brochure Generally, the sponsor is responsible for ensuring that an up-to-date IB is developed.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 59
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A.1.1 Development of the Investigator’s Brochure Generally, the sponsor is responsible for ensuring that an up-to-date IB is developed.
CB7K-DOM019-C52registry slot CB7K-DOM019-T06-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

52. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 61

Narrow public claim

A.3.4 Physical, Chemical and Pharmaceutical Properties and Formulation A description should be provided of the investigational product substance(s) (including the chemical and/or structural formula(e)), and a brief summary should be given of the relevant physical, chemical and pharmaceutical properties.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 61
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A.3.4 Physical, Chemical and Pharmaceutical Properties and Formulation A description should be provided of the investigational product substance(s) (including the chemical and/or structural formula(e)), and a brief summary should be given of the relevant physical, chemical and pharmaceutical properties.
CB7K-DOM019-C53registry slot CB7K-DOM019-T06-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

53. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 61

Narrow public claim

A.3.5 Nonclinical Studies Introduction The results of all relevant nonclinical pharmacology, toxicology, pharmacokinetic and investigational product metabolism studies should be provided in summary form.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 61
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A.3.5 Nonclinical Studies Introduction The results of all relevant nonclinical pharmacology, toxicology, pharmacokinetic and investigational product metabolism studies should be provided in summary form.
CB7K-DOM019-C54registry slot CB7K-DOM019-T06-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

54. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 65

Narrow public claim

B.2.2 A summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 65
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.2.2 A summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.
CB7K-DOM019-C55registry slot CB7K-DOM019-T06-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

55. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 65

Narrow public claim

B.2.5 A statement that the trial will be conducted in compliance with the protocol, Good Clinical Practice (GCP) and the applicable regulatory requirement(s).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 65
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.2.5 A statement that the trial will be conducted in compliance with the protocol, Good Clinical Practice (GCP) and the applicable regulatory requirement(s).
CB7K-DOM019-C56registry slot CB7K-DOM019-T06-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

56. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 66

Narrow public claim

B.4.2 A description of the type and design of trial to be conducted (e.g., double-blind, placebo-controlled, parallel design, adaptive design, platform/umbrella/basket, trials with decentralised elements) and a schematic diagram of trial design, procedures and stages.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 66
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.4.2 A description of the type and design of trial to be conducted (e.g., double-blind, placebo-controlled, parallel design, adaptive design, platform/umbrella/basket, trials with decentralised elements) and a schematic diagram of trial design, procedures and stages.
CB7K-DOM019-C57registry slot CB7K-DOM019-T06-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

57. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 66

Narrow public claim

B.4.3 A description of the measures taken to minimise/avoid bias, including: (a) Randomisation (b) Blinding B.4.4 A description of the investigational product(s) and the dosage and dosage regimen of the investigational product(s), including a description of the dosage form, packaging and labelling.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 66
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.4.3 A description of the measures taken to minimise/avoid bias, including: (a) Randomisation (b) Blinding B.4.4 A description of the investigational product(s) and the dosage and dosage regimen of the investigational product(s), including a description of the dosage form, packaging and labelling.
CB7K-DOM019-C58registry slot CB7K-DOM019-T06-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

58. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 67

Narrow public claim

Conversely, the participant may decide to withdraw from the trial or stop treatment with the investigational product (see sections 2.8.10(l), 2.8.10(m) and 2.9.1).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 67
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Conversely, the participant may decide to withdraw from the trial or stop treatment with the investigational product (see sections 2.8.10(l), 2.8.10(m) and 2.9.1).
CB7K-DOM019-C59registry slot CB7K-DOM019-T06-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

59. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 67

Narrow public claim

B.7 Treatment and Interventions for Participants B.7.1 The treatment(s) to be administered, including the name(s) of all the product(s), the dose(s), the dosing schedule(s), the criteria for dose adjustment(s), the route/mode(s) of administration and the treatment period(s), including the follow-up period(s) for participants for each investigational product treatment/trial treatment group/arm of the trial.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 67
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.7 Treatment and Interventions for Participants B.7.1 The treatment(s) to be administered, including the name(s) of all the product(s), the dose(s), the dosing schedule(s), the criteria for dose adjustment(s), the route/mode(s) of administration and the treatment period(s), including the follow-up period(s) for participants for each investigational product treatment/trial treatment group/arm of the trial.
CB7K-DOM019-C60registry slot CB7K-DOM019-T06-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

60. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 68

Narrow public claim

B.10 Statistical Considerations B.10.1 A description of the statistical methods to be employed, including timing and purpose of any planned interim analysis(ses) and the statistical criteria for the stopping of the trial.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 68
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.10 Statistical Considerations B.10.1 A description of the statistical methods to be employed, including timing and purpose of any planned interim analysis(ses) and the statistical criteria for the stopping of the trial.
CB7K-DOM019-C61registry slot CB7K-DOM019-T07-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

61. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 68

Narrow public claim

B.10.2 The number of participants planned to be enrolled and the reason for the choice of sample size, including reflections on or calculations of the power of the trial and clinical justification.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 68
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.10.2 The number of participants planned to be enrolled and the reason for the choice of sample size, including reflections on or calculations of the power of the trial and clinical justification.
CB7K-DOM019-C62registry slot CB7K-DOM019-T07-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

62. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 69

Narrow public claim

B.14.2 The identification of data to be recorded directly into the data acquisition tools (i.e., no prior written or electronic record of data) and considered to be the source record.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 69
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
B.14.2 The identification of data to be recorded directly into the data acquisition tools (i.e., no prior written or electronic record of data) and considered to be the source record.
CB7K-DOM019-C63registry slot CB7K-DOM019-T07-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

63. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 70

Narrow public claim

C.2 Management of Essential Records C.2.1 Records should be identifiable and version controlled (when appropriate) and should include authors, reviewers and approvers as appropriate, along with date and signature (electronic or physical), where necessary.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 70
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.2 Management of Essential Records C.2.1 Records should be identifiable and version controlled (when appropriate) and should include authors, reviewers and approvers as appropriate, along with date and signature (electronic or physical), where necessary.
CB7K-DOM019-C64registry slot CB7K-DOM019-T07-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

64. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 70

Narrow public claim

C.2.2 For activities that are transferred or delegated to service providers by the sponsor or investigator/institution, respectively, arrangements should be made for the access and management of the essential records throughout the trial and for their retention following completion of the trial.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 70
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.2.2 For activities that are transferred or delegated to service providers by the sponsor or investigator/institution, respectively, arrangements should be made for the access and management of the essential records throughout the trial and for their retention following completion of the trial.
CB7K-DOM019-C65registry slot CB7K-DOM019-T07-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

65. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 71

Narrow public claim

C.2.6 The sponsor and investigator/institution should retain the essential records in a way that ensures that they remain complete, readable and readily available and are directly accessible upon request by regulatory authorities, monitors and auditors.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 71
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.2.6 The sponsor and investigator/institution should retain the essential records in a way that ensures that they remain complete, readable and readily available and are directly accessible upon request by regulatory authorities, monitors and auditors.
CB7K-DOM019-C66registry slot CB7K-DOM019-T07-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

66. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 71

Narrow public claim

C.2.7 The sponsor and investigator/institution should ensure the retention of the essential records required to fulfil their responsibility.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 71
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.2.7 The sponsor and investigator/institution should ensure the retention of the essential records required to fulfil their responsibility.
CB7K-DOM019-C67registry slot CB7K-DOM019-T07-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

67. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 73

Narrow public claim

C.3.2 Applying the criteria in section C.3.1, the trial records that are considered essential are listed in the Essential Records Table, and these should be retained when produced.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 73
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.3.2 Applying the criteria in section C.3.1, the trial records that are considered essential are listed in the Essential Records Table, and these should be retained when produced.
CB7K-DOM019-C68registry slot CB7K-DOM019-T07-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

68. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 74

Narrow public claim

C.3.3 For some trial records listed in the Essential Record Table, their presence and nature are dependent on the trial design, trial conduct and risk proportionate management of the trial and may not be produced.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 74
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
C.3.3 For some trial records listed in the Essential Record Table, their presence and nature are dependent on the trial design, trial conduct and risk proportionate management of the trial and may not be produced.
CB7K-DOM019-C69registry slot CB7K-DOM019-T07-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

69. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 77

Narrow public claim

(see ICH E2A) An important medical event that may not be immediately life-threatening or result in death or hospitalisation, that may jeopardise the participant or that may require intervention to prevent serious outcomes (see ICH E2A and E19) should generally be considered as serious.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 77
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(see ICH E2A) An important medical event that may not be immediately life-threatening or result in death or hospitalisation, that may jeopardise the participant or that may require intervention to prevent serious outcomes (see ICH E2A and E19) should generally be considered as serious.
CB7K-DOM019-C70registry slot CB7K-DOM019-T07-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

70. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 79

Narrow public claim

Clinical Trial/Study Report (CSR) A documented description of a trial of any investigational product conducted in human participants, in which the clinical and statistical description, presentations and analyses are fully integrated into a single report (see ICH E3 Structure and Content of Clinical Study Reports).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
ICH E6(R3) Guideline for Good Clinical Practice
Section locator
PDF page 79
Captured
2026-08-11
Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Clinical Trial/Study Report (CSR) A documented description of a trial of any investigational product conducted in human participants, in which the clinical and statistical description, presentations and analyses are fully integrated into a single report (see ICH E3 Structure and Content of Clinical Study Reports).